trending Market Intelligence /marketintelligence/en/news-insights/trending/6-bxvdjkuebswi6h0qax6a2 content esgSubNav
In This List

Lansen Pharmaceutical Holdings CFO/executive director resigns

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Lansen Pharmaceutical Holdings CFO/executive director resigns

Lansen Pharmaceutical Holdings Ltd. said Hou Song resigned as CFO, executive director and an authorized representative of the company, effective Oct. 20.

Hou resigned to pursue an opportunity elsewhere and not as a result of any disagreement with the company, Lansen Pharmaceutical said in a statement.

The Chinese drugmaker's CEO and executive managing director, Chen Li, has been named as the authorized representative of the company in the meanwhile.